| Closed |
S0809 |
Cholangiocarcinoma Ph II capecitabine, gemcitabine, RT |
12/1/2008 |
10/1/2012 |
100% |
|
Published
|
| Closed |
S9911 |
CHOP followed by Iodine-131-Labeled Monoclonal Anti-B1 Antibody |
5/15/1999 |
6/1/2000 |
100% |
|
Published
|
| Closed |
S9800 |
CHOP x 6 followed by Rituximab chimeric monoclonal Anti-CD20 antibody X 4 |
2/15/1998 |
11/15/1998 |
100% |
|
Published
|
| Closed |
SWOG-8026 |
Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinoma of the Penis |
9/15/1980 |
8/1/1986 |
|
|
Published
|
| Closed |
SWOG-8520 |
Cis-Diamminedichloroplatinum (II), Methotrexate and Bleomycin in the Treatment of Advanced Epidermoid Carcinoma of the Penis |
9/1/1986 |
9/1/1994 |
100% |
|
Published
|
| Closed |
S0124 |
Cis/Irinotecan vs. Cis/VP-16 in Extensive SCLC |
11/1/2002 |
3/1/2007 |
99% |
|
Published
|
| Closed |
S0023 |
Cis/VP-16/RT/Consol. Doc followed by ZD1839/Placebo /IIIA & selected IIIB NSCLC |
6/15/2001 |
4/15/2005 |
74% |
|
Published
|
| Closed |
S0220 |
Cis/VP-16/RT/Surgery/Doc/Selected IIB, Stage IIIA or IIIB (Pancoast Tumors) |
7/1/2003 |
10/1/2007 |
92% |
|
Published
|
| Closed |
SWOG-8850 |
Cisplatin and Novobiocin in the Treatment of Stage IV, Stage IIIb or Locally Recurrent Tumor After Radiation Therapy of Non-Small Cell Lung Cancer (NSCLC) |
8/15/1988 |
6/1/1990 |
72% |
|
Published
|
| Closed |
S0533 |
Cisplatin/Etoposide/RT/Docetaxel and Three Cohorts of Bevacizumab-Advanced Stage III NSCLC |
6/15/2006 |
3/1/2010 |
16% |
|
Published
|
| Closed |
SWOG-8897 |
CMF vs. CAF ± Tamoxifen in High-Risk, Node Neg. |
7/15/1989 |
2/1/1993 |
100% |
|
Published
|
| Closed |
SWOG-7436 |
CMFVP vs Melphalan for operable breast cancer |
1/9/1975 |
7/18/1979 |
100% |
|
Published
|
| Closed |
S9635 |
COLORECTAL |
4/1/1998 |
9/15/2000 |
49% |
|
Published
|
| Closed |
S9923 |
COLORECTAL |
6/1/2000 |
8/1/2001 |
100% |
|
Published
|
| Closed |
S0030 |
COLORECTAL |
2/1/2003 |
2/1/2005 |
48% |
|
Published
|
| Closed |
S0336 |
COLORECTAL |
4/15/2004 |
9/1/2005 |
70% |
|
Published
|
| Closed |
S0600 |
Colorectal Ph III irinotecan-based chemo + cetuximab or bevacizumab |
6/15/2007 |
11/10/2010 |
11% |
|
Published
|
| Closed |
SWOG-8460 |
Combination Chemotherapy (COPE) and Radiation Therapy for Extensive Small Cell Lung Cancer |
10/15/1984 |
10/1/1986 |
|
|
Published
|
| Closed |
SWOG-7613 |
Combination Chemotherapy for advanced Soft Tissue Sarcomas Utilizing Adriamycin, DIC, Cyclophosphamide and Dactinomycin |
6/1/1976 |
10/17/1979 |
|
|
Published
|
| Closed |
SWOG-8076 |
Combination Chemotherapy for the Treatment of ER- or Pilot Hormone-Refractory Patients with Metastatic Breast Cancer |
10/21/1980 |
9/10/1982 |
|
|
Published
|
